This observational study is designed to collect data on the use of the drug Lecigon® in daily clinical practice. The study is organised and funded by a pharmaceutical company called Britannia Pharmaceuticals Ltd (Britannia). Lecigon® is prescribed by physicians in advanced Parkinson's disease when patients suffer from uncontrollable fluctuations in mobility, so-called motor fluctuations, which cannot be adjusted well with oral treatment, i.e. medication for swallowing. In this study, data on the effect and possible side effects from everyday treatment with Lecigon® will be collected and scientifically evaluated. The study is intended to supplement the results of previous clinical studies with clinical data in routine medical care, collected from approximately 300 patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in OFF time from baseline up to 24 months, or treatment or study discontinuation
Timeframe: 24 months
Change in activities of daily living from baseline up to 24 months, or treatment or study discontinuation
Timeframe: 24 months
Change in Daily Levodopa dose from baseline up to 24 months, or treatment or study discontinuation
Timeframe: 24 months
Usage of other Anti-Parkinsonian medicinal products from baseline up to 24 months, or treatment or study discontinuation
Timeframe: 24 months
Usage of the Lecigon® pump from baseline up to 24 months, or treatment or study discontinuation
Timeframe: 24 months
Change in Clinical Global Impression of Improvement (CGI-I) from baseline up to 24 months, or treatment or study discontinuation
Timeframe: 24 months
Change in Patient Global Impression of Change from baseline up to 24 months, or treatment or study discontinuation
Timeframe: 24 months
Satisfaction with treatment from baseline up to 24 months or treatment or study discontinuation
Timeframe: 24 months
Occurrence of AEs and SAEs from baseline up to 24 months or treatment or study discontinuation
Timeframe: 24 months